Literature DB >> 10600859

Comparison of SERCA1 and SERCA2a expressed in COS-1 cells and cardiac myocytes.

C Sumbilla1, M Cavagna, L Zhong, H Ma, D Lewis, I Farrance, G Inesi.   

Abstract

Cultured COS-1 cells, as well as chicken embryonic and neonatal rat cardiac myocytes, were infected with recombinant adenovirus vectors to define limiting factors in the expression and Ca2+ transport function of recombinant sarcoplasmic-endoplasmic reticulum Ca(2+) (SERCA) isoforms. Titration experiments showed that all COS-1 cells and myocytes in culture could be infected by an adenovirus titer of 10 plaque-forming units (pfu) per seeded cell. Raising the adenovirus titer further yielded higher protein expression up to an asymptotic limit for functional, membrane-bound SERCA protein. The asymptotic behavior of SERCA expression was not transcription related but was due to posttranscriptional events. The minimal (-268) cardiac troponin T (cTnT) promoter was a convenient size for adenovirus vector construction and manifested tight muscle specificity. However, its efficiency was lower than that of the nonspecific cytomegalovirus (CMV) promoter. At any rate, identical maximal levels of SERCA expression were obtained with the CMV and the cTnT promoter, as long as the viral titer was adjusted to compensate for transcription efficiency. A maximal threefold increase of total SERCA protein expression over the level of the endogenous SERCA of control myocytes was reached (a sevenfold increase compared with the endogenous SERCA of the same infected myocytes due to reduction of endogenous SERCA after infection). In contrast with previous reports [Ji et al. Am. J. Physiol. 276 (Heart Circ. Physiol. 45): H89-H97, 1999], a higher kinetic turnover was demonstrated for the SERCA1 compared with the SERCA2a isoform as shown by a 5.0- versus 2.6-fold increase in calcium uptake rate accompanying maximal expression of recombinant SERCA1 or SERCA2a, respectively. This information is deemed necessary for studies attempting to modify myocardial cell function by manipulation of SERCA expression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10600859     DOI: 10.1152/ajpheart.1999.277.6.H2381

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  18 in total

1.  Contractile effects of adenovirally-mediated increases in SERCA2a activity: a comparison between adult rat and rabbit ventricular myocytes.

Authors:  Babar Chaudhri; Federica del Monte; Roger J Hajjar; Sian E Harding
Journal:  Mol Cell Biochem       Date:  2003-09       Impact factor: 3.396

2.  Adenoviral SERCA1 overexpression triggers an apoptotic response in cultured neonatal but not in adult rat cardiomyocytes.

Authors:  Guimei Wu; Xilin Long; José Marín-García
Journal:  Mol Cell Biochem       Date:  2004-12       Impact factor: 3.396

Review 3.  Endoplasmic reticulum Ca(2+) handling in excitable cells in health and disease.

Authors:  Grace E Stutzmann; Mark P Mattson
Journal:  Pharmacol Rev       Date:  2011-07-07       Impact factor: 25.468

4.  Dual gene therapy with SERCA1 and Kir2.1 abbreviates excitation without suppressing contractility.

Authors:  Irene L Ennis; Ronald A Li; Anne M Murphy; Eduardo Marbán; H Bradley Nuss
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

5.  Silencing calcineurin A subunit reduces SERCA2 expression in cardiac myocytes.

Authors:  Anand Mohan Prasad; Giuseppe Inesi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-11-05       Impact factor: 4.733

6.  Regulation and rate limiting mechanisms of Ca2+ ATPase (SERCA2) expression in cardiac myocytes.

Authors:  Anand Mohan Prasad; Giuseppe Inesi
Journal:  Mol Cell Biochem       Date:  2011-10-01       Impact factor: 3.396

Review 7.  Targeting signaling pathways in heart failure by gene transfer.

Authors:  Briain D MacNeill; Motoya Hayase; Roger J Hajjar
Journal:  Curr Atheroscler Rep       Date:  2003-05       Impact factor: 5.113

8.  Limited functional and metabolic improvements in hypertrophic and healthy rat heart overexpressing the skeletal muscle isoform of SERCA1 by adenoviral gene transfer in vivo.

Authors:  J Michael O'Donnell; Aaron Fields; Xianyao Xu; Shamim A K Chowdhury; David L Geenen; Jian Bi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-10-24       Impact factor: 4.733

9.  Sarcoplasmic reticulum Ca2+ uptake and leak properties, and SERCA isoform expression, in type I and type II fibres of human skeletal muscle.

Authors:  C R Lamboley; R M Murphy; M J McKenna; G D Lamb
Journal:  J Physiol       Date:  2014-01-27       Impact factor: 5.182

10.  Development of a Sensitive Assay for SERCA Activity Using FRET Detection of ADP.

Authors:  Meng Jing; Raffaello Verardi; Gianluigi Veglia; Michael T Bowser
Journal:  Anal Methods       Date:  2014-03-07       Impact factor: 2.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.